I’M one of the ten million people in the UK with arthritis. Nearly half of sufferers depend on the use of painkillers to manage symptoms. But GPs should tell patients to exercise and lose weight ...

Scientists have developed a drug that can bring remarkable improvements to the lives of hundreds of thousands of arthritis sufferers. A single course of treatment will provide relief from ...

Supplements might seem like a good strategy for joint pain. But in many cases, they may do more harm than good.

Arthritis drugs already available for prescription have the potential to halt lingering lung problems that can last months or years after COVID-19 infections, new research from the School of Medicine ...

Pfizer has received approval from the US FDA for its rheumatoid arthritis (RA) drug, Xeljanz, which is the first approved RA treatment in a new class of medicines known as Janus kinase inhibitors ...

Tremfya is a prescription drug used for psoriasis and psoriatic arthritis. Find out about possible interactions with alcohol, ...

Arthritis drugs already available for prescription have the potential to halt lingering lung problems that can last months or years after COVID-19 infections, new research from the University of ...

Doctors have the expertise to assess the severity and type of arthritis, whether osteoarthritis, rheumatoid arthritis, or ...

A new oral treatment for psoriatic arthritis, Celgene's Otezla ... the immunology field currently dominated by the TNF blocker drugs, led by AbbVie's Humira. The oral treatment has a novel ...

Sep. 5, 2024 — Clinical studies have shown that periodontal disease with Aggregatibacter actinomycetemcomitans can exacerbate symptoms of rheumatoid arthritis (RA), but the molecular mechanisms ...

This scale was developed to help doctors measure disease activity in people with rheumatoid arthritis ... and slow down disease progression. Medications that can slow the progression of RA ...

Here’s the tricky thing about knee arthritis: Some don’t have symptoms, while others are consistently sidelined from ...